YIDU TECH Inc. (HKG:2158) shares plummeted by 5.27% on Monday, November 12th, amid concerns over the company's high valuation and subdued revenue growth forecasts.
The healthcare services provider's stock had gained 45% over the past month and 31% in the last year, fueled by investor optimism. However, YIDU TECH's price-to-sales (P/S) ratio currently stands at 6.7x, significantly higher than the industry average of 4.6x in Hong Kong.
While a high P/S ratio can sometimes be justified by strong revenue growth prospects, analysts estimates suggest YIDU TECH's revenue is expected to grow by only 18% per year over the next three years, on par with the industry's forecasted growth rate. This has raised doubts about whether the company's elevated valuation can be sustained in the long term.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。